The effects of the pre-treatment of intravenous nimodipine on Na+-K+/Mg+2 ATPase, Ca+2/Mg+2 ATPase, lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat

Neurological Research

Volumn 23, Issue 1, 2001, Pages 96-104

  Ildan, F ^a   Gocer A I ^a   Tuna, M ^a   Polat, S ^a   Kaya, M ^a   Isbir, T ^a   Cetinalp E ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Ca+2 Mg+2 ATPase; Ischemia; Lipid peroxidation; Na+ K+ Mg+2 ATPase; Nimodipine; Rat

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM; CALCIUM ANTAGONIST; MAGNESIUM; MALONALDEHYDE; NIMODIPINE; POTASSIUM; SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ULTRASTRUCTURE; ENZYME ACTIVITY; LIPID ANALYSIS; LIPID PEROXIDATION; MEMBRANE BINDING; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; RAT;

ANIMALS; BRAIN ISCHEMIA; CA(2+) MG(2+)-ATPASE; CEREBRAL CORTEX; ENERGY METABOLISM; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NA(+)-K(+)-EXCHANGING ATPASE; NEURONS; NIMODIPINE; RATS; RATS, WISTAR;

EID: 0035142677     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164101101198208     Document Type: Article

References (65)

1. Beyond cerebral blood flow metabolism and ischemic thresholds. An examination of the role of calcium in the initiation of cerebral infarction
2. Reperfusion of the ischemic myocardium
3. Calcium dependence of toxic cell death, a final common pathway
4. Cell damage in the brain. A speculative synthesis
5. Arachidonic acid metabolism in ischemic neuronal damage
6. Effect of calcium antagonist and agonist on free fatty acid liberation in the ischemic brain of rats
7. Ischemic injury in the brain role of oxygen radical mediated process
8. Increased phospholipase C activity after experimental brain injury
9. The role of calcium and cellular membrane dysfunction in experiment trauma and subarachnoid hemorrhage
10. Free fatty acid accumulation in the pathogenesis and therapy of ischemic-anoxic brain injury
11. Effect of nimodipine (Bay e 9736) on post ischemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF)
12. Effect of calcium antagonist nimodipine on cerebral blood flow and metabolism on primate
13. Pial arterial vasodilatation by intravenous nimodipine in cats
14. Effects of nimodipine (Bayer 9736) on cerebral circulation in cats
15. Nimodipine inhibits, carbocyclic thromboxane-induced contractions of cerebral arteries
16. Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries
17. Nimodipine a new calcium antagonistic drug with a preferential cerebrovascular action
18. +) ATPase, lipid peroxidation and alpha motor neuron function
19. + ATPase activity and tissue water content of spinal cord following experimental traumatic injury
20. + ATPase activity and B endorphin content in acute ischemic brain with and without naloxone treatment
21. +2 ATPase activity, lipid peroxidation and ultrastructural findings following experimental spinal cord injury with and without intravenous methylprednisolone treatment
22. +2 ATPase and lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat
23. +2 ATPase activity and lipid peroxidation and ultrastructural findings following cerebral contusion in rat
24. Effects of Naloxone on sodium- and potassium-activated magnesium-dependent adenisone-5′-triphosphatase activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury
25. Lipid requirement of the membrane sodium plus potassium ion dependent adenosine triphosphatase system
26. The role of calcium in neuronal function
27. Cerebral circulation and metabolism
28. Focal cerebral ischemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion
29. Middle cerebral artery occlusion in rats. A neurological and pathological evaluation of reproducible model
30. The effect of nimodipine on intracranial pressure. Volume-pressure studies in a primate model
31. Nimodipine levels in gerbil brain following parenteral drug administration
32. Action of lithium on ATPase in transmitter release from rat iris
33. The role of cation-activated ATPases in transmitter release from rat iris
34. Protein measurement with the folin phenol reagent
35. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
36. 4 solutions and fixation
37. Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia
38. Cerebral phosphoinositide, triacylglycerol and energy metabolism in reversible ischemia: Origin and fate of free fatty acids
39. The effect of the calcium antagonist nimodipine on the gerbil model of experimental cerebral ischemia
40. A controlled trial of nimodipine in acute ischemia stroke
41. Effects of nimodipine on acute focal cerebral ischemia
42. Failure of nimodipine to prevent ischemic neuronal damage in rats
43. Effect of pre-treatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion
44. Calcium antagonism. A new approach
45. The effects of a calcium antagonist nimodipine upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischemia
46. The therapeutic value of nimodipine in experimental focal cerebral ischemia: Neurological outcome and histopathological findings
47. Cerebrovascular effects of the calcium antagonistic dehydropyridine derivative nimodipine in animal experiments
48. The exclusion of the cerebral circulation: Effect on the 'in vivo' platelet aggregation
49. Prevention of the postischemic impaired perfusion of the brain by nimodipine
50. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog
51. Neuroprotective effect of nimodipine is not mediated by increased cerebral blood flow after transient forebrain ischemia in rats
52. Effect of nimodipine on cerebral metabolism, during ischemia and recirculation
53. Effect of nimodipine on cerebral functional and metabolic recovery following ischemia in the rat brain
54. Calcium currents in mammalian central neurons
55. Lipid peroxidation in focal cerebral ischemia
56. +-K+ ATPase activity during ischemic and post ischemic reperfusion in the mongolian gerbil
57. +-K+ ATPase in the microsomal fraction of guinea pig brain
58. Alteration of cyclic nucleotide-related enzymes and ATPase during unilateral ischemia and recirculation in gerbil cerebral cortex
59. +2 antagonist attenuation of brain free fatty acid liberation during global ischemia
60. Vasodilator profile of a new 1,4 dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl-1,4-dihydropyridine-3,5 dicarboxylic acid 3(2-(N-benzyl-N-methylamine) ethyl ester 5-methyl ester hydrochloride (YC-93)
61. Autoxidation of polyunsaturated fatty acids. II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides
62. Spectrofluorescent detection of malondialdehyde as a measure of lipid free radical damage in response to ethanol potentiation of spinal cord trauma
63. +2 ATPase activity and the 1251 calmodulin binding in brain membranes